Authors:
Bos, AME
de Vries, EGE
Dombernovsky, P
Aamdal, S
Uges, DRA
Schrijvers, D
Wanders, J
Roelvink, MWJ
Hanauske, AR
Bortini, S
Capriati, A
Crea, AEG
Vermorken, JB
Citation: Ame. Bos et al., Pharmacokinetics of MEN-10755, a novel anthracycline disaccharide analogue, in two phase I studies in adults with advanced solid tumours, CANC CHEMOT, 48(5), 2001, pp. 361-369
Authors:
Koopmans, P
Gidding, CEM
de Graaf, SSN
Uges, DRA
Citation: P. Koopmans et al., An automated method for the bioanalysis of vincristine suitable for therapeutic drug monitoring and pharmacokinetic studies in young children, THER DRUG M, 23(4), 2001, pp. 406-409
Authors:
Gelevert, T
Messerschmidt, J
Meinardi, MT
Alt, F
Gietema, JA
Franke, JP
Sleijfer, DT
Uges, DRA
Citation: T. Gelevert et al., Adsorptive voltametry to determine platinum levels in plasma from testicular cancer patients treated with cisplatin, THER DRUG M, 23(2), 2001, pp. 169-173
Authors:
Bosch, TM
van der Werf, TS
Uges, DRA
Ligtenberg, JJM
Fijen, JW
Tulleken, JE
Zijlstra, JG
Citation: Tm. Bosch et al., Antidepressants self-poisoning and ICU admissions in a University Hospitalin the Netherlands, PHARM WORLD, 22(3), 2000, pp. 92-95
Authors:
van de Belt, H
Neut, D
Uges, DRA
Schenk, W
van Horn, JR
van der Mei, HC
Busscher, HJ
Citation: H. Van De Belt et al., Surface roughness, porosity and wettability of gentamicin-loaded bone cements and their antibiotic release, BIOMATERIAL, 21(19), 2000, pp. 1981-1987
Authors:
Gietema, JA
Meinardi, MT
Messerschmidt, J
Gelevert, T
Alt, F
Uges, DRA
Sleijfer, DT
Citation: Ja. Gietema et al., Circulating plasma platinum more than 10 years after cisplatin treatment for testicular cancer, LANCET, 355(9209), 2000, pp. 1075-1076
Authors:
Paridaens, R
Uges, DRA
Barbet, N
Choi, L
Seeghers, M
van der Graaf, WTA
Groen, HJM
Dumez, H
Van Buuren, I
Muskiet, F
Capdeville, R
van Oosterom, AT
de Vries, EGE
Citation: R. Paridaens et al., A phase I study of a new polyamine biosynthesis inhibitor, SAM486A, in cancer patients with solid tumours, BR J CANC, 83(5), 2000, pp. 594-601
Authors:
Fokkema, E
Verweij, J
van Oosterom, AT
Uges, DRA
Spinelli, R
Valota, O
de Vries, EGE
Green, HJM
Citation: E. Fokkema et al., A prolonged methoxymorpholino doxorubicin (PNU-152243 or MMRDX) infusion schedule in patients with solid tumours: a phase 1 and pharmacokinetic study, BR J CANC, 82(4), 2000, pp. 767-771
Authors:
Fokkema, E
Groen, HJM
Bauer, J
Uges, DRA
Weil, C
Smith, IE
Citation: E. Fokkema et al., Phase II study of oral platinum drug JM216 as first-line treatment in patients with small-cell long cancer, J CL ONCOL, 17(12), 1999, pp. 3822-3827
Authors:
de Jong, RS
Mulder, NH
Uges, DRA
Sleijfer, DT
Hoppener, FJP
Groen, HJM
Willemse, PHB
van der Graaf, WTA
de Vries, EGE
Citation: Rs. De Jong et al., Phase I and pharmacokinetic study of the topoisomerase II catalytic inhibitor fostriecin, BR J CANC, 79(5-6), 1999, pp. 882-887
Citation: Dra. Uges, Could a selective serotonin reuptake inhibitor (SSRI) incite someone to (attempt) murder?, J FOREN SCI, 43(6), 1998, pp. 1260-1260